Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Cardiac Rehabilitation for Women: A Systematic Review of Barriers and Solutions.

Supervía M, Medina-Inojosa JR, Yeung C, Lopez-Jimenez F, Squires RW, Pérez-Terzic CM, Brewer LC, Leth SE, Thomas RJ.

Mayo Clin Proc. 2017 Mar 13. pii: S0025-6196(17)30026-5. doi: 10.1016/j.mayocp.2017.01.002. [Epub ahead of print] Review.

2.

Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis.

Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Reyes S, Puceat M, Michalak M, Terzic A, Perez-Terzic C.

J Mol Cell Cardiol. 2016 Mar;92:63-74. doi: 10.1016/j.yjmcc.2016.01.022. Epub 2016 Jan 27.

PMID:
26826378
3.

Musclin is an activity-stimulated myokine that enhances physical endurance.

Subbotina E, Sierra A, Zhu Z, Gao Z, Koganti SR, Reyes S, Stepniak E, Walsh SA, Acevedo MR, Perez-Terzic CM, Hodgson-Zingman DM, Zingman LV.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):16042-7. doi: 10.1073/pnas.1514250112. Epub 2015 Dec 14.

4.

Systems biology surveillance decrypts pathological transcriptome remodeling.

Faustino RS, Wyles SP, Groenendyk J, Michalak M, Terzic A, Perez-Terzic C.

BMC Syst Biol. 2015 Jul 17;9:36. doi: 10.1186/s12918-015-0177-8.

5.

Cardiopoietic index predicts heart repair fitness of patient-derived stem cells.

Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauën S, Terzic A, Behfar A.

Biomark Med. 2015;9(7):639-49. Epub 2015 May 27.

6.

Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy.

Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, Crespo-Diaz RJ, McDonald RJ, Wyles SP, Zlatkovic-Lindor J, Nelson TJ, Terzic A.

J Am Heart Assoc. 2015 May 11;4(5). pii: e001614. doi: 10.1161/JAHA.114.001614.

7.

Efficacy of intervertebral disc regeneration with stem cells - a systematic review and meta-analysis of animal controlled trials.

Wang Z, Perez-Terzic CM, Smith J, Mauck WD, Shelerud RA, Maus TP, Yang TH, Murad MH, Gou S, Terry MJ, Dauffenbach JP, Pingree MJ, Eldrige JS, Mohammed K, Benkhadra K, van Wijnen AJ, Qu W.

Gene. 2015 Jun 10;564(1):1-8. doi: 10.1016/j.gene.2015.03.022. Epub 2015 Mar 19. Review.

PMID:
25796605
8.

Regenerative principles enrich cardiac rehabilitation practice.

Behfar A, Terzic A, Perez-Terzic CM.

Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S169-75. doi: 10.1097/PHM.0000000000000147. Review.

9.

Regenerative rehabilitation: a new future?

Perez-Terzic C, Childers MK.

Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S73-8. doi: 10.1097/PHM.0000000000000211.

10.

Stem cell therapy for intervertebral disk regeneration.

Gou S, Oxentenko SC, Eldrige JS, Xiao L, Pingree MJ, Wang Z, Perez-Terzic C, Qu W.

Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S122-31. doi: 10.1097/PHM.0000000000000152. Review.

PMID:
25122106
11.

iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes.

Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A.

Circ Cardiovasc Genet. 2014 Oct;7(5):667-76. doi: 10.1161/CIRCGENETICS.113.000298. Epub 2014 Jul 30.

12.

Inpatient rehabilitation outcomes for patients receiving left ventricular assist device.

Alsara O, Reeves RK, Pyfferoen MD, Trenary TL, Engen DJ, Vitse ML, Kessler SM, Kushwaha SS, Clavell AL, Thomas RJ, Lopez-Jimenez F, Park SJ, Perez-Terzic CM.

Am J Phys Med Rehabil. 2014 Oct;93(10):860-8. doi: 10.1097/PHM.0000000000000101.

PMID:
24901760
13.

Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction.

Suresh R, Li X, Chiriac A, Goel K, Terzic A, Perez-Terzic C, Nelson TJ.

J Mol Cell Cardiol. 2014 Sep;74:13-21. doi: 10.1016/j.yjmcc.2014.04.017. Epub 2014 May 4.

14.

Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy?

Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ.

J Cardiopulm Rehabil Prev. 2014 Jul-Aug;34(4):233-40. doi: 10.1097/HCR.0000000000000050. Review.

PMID:
24531204
15.

Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy.

Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A.

J Am Heart Assoc. 2013 Dec 5;2(6):e000410. doi: 10.1161/JAHA.113.000410.

16.

Stem cell systems informatics for advanced clinical biodiagnostics: tracing molecular signatures from bench to bedside.

Faustino RS, Arrell DK, Folmes CD, Terzic A, Perez-Terzic C.

Croat Med J. 2013 Aug;54(4):319-29. Review.

17.

CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction.

Suresh R, Chiriac A, Goel K, Villarraga HR, Lopez-Jimenez F, Thomas RJ, Terzic A, Nelson TJ, Perez-Terzic C.

J Cardiovasc Transl Res. 2013 Oct;6(5):787-97. doi: 10.1007/s12265-013-9502-z. Epub 2013 Aug 10.

PMID:
23934537
18.

Cardiac rehabilitation services in low- and middle-income countries: a scoping review.

Shanmugasegaram S, Perez-Terzic C, Jiang X, Grace SL.

J Cardiovasc Nurs. 2014 Sep-Oct;29(5):454-63. doi: 10.1097/JCN.0b013e31829c1414. Review.

PMID:
23839574
19.

Metabolome and metaboproteome remodeling in nuclear reprogramming.

Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ, Terzic A.

Cell Cycle. 2013 Aug 1;12(15):2355-65. doi: 10.4161/cc.25509. Epub 2013 Jul 8.

20.

Improving cardiac rehabilitation attendance and completion through quality improvement activities and a motivational program.

Pack QR, Johnson LL, Barr LM, Daniels SR, Wolter AD, Squires RW, Perez-Terzic CM, Thomas RJ.

J Cardiopulm Rehabil Prev. 2013 May-Jun;33(3):153-9. doi: 10.1097/HCR.0b013e31828db386.

21.

Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.

Yamada S, Nelson TJ, Kane GC, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Perez-Terzic C, Terzic A.

J Physiol. 2013 Sep 1;591(17):4335-49. doi: 10.1113/jphysiol.2013.252288. Epub 2013 Apr 8.

22.

Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.

Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ.

Stem Cells. 2013 Jul;31(7):1298-308. doi: 10.1002/stem.1389.

23.

Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A.

J Cardiovasc Transl Res. 2013 Feb;6(1):10-21. doi: 10.1007/s12265-012-9431-2. Epub 2012 Dec 18.

24.

Availability and characteristics of cardiovascular rehabilitation programs in South America.

Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibañez C, Burdiat G, Gonzalez G, Gonzalez K, Finizola B, Fernandez R, Paniagua M, Thomas RJ, Gonzalez-Moreno J, Rodriguez-Escudero JP, Perez-Terzic C.

J Cardiopulm Rehabil Prev. 2013 Jan-Feb;33(1):33-41. doi: 10.1097/HCR.0b013e318272153e.

PMID:
23235320
25.

Exercise in cardiovascular diseases.

Perez-Terzic CM.

PM R. 2012 Nov;4(11):867-73. doi: 10.1016/j.pmrj.2012.10.003. Review.

PMID:
23174552
26.

Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review.

Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, Trejo-Gutierrez J, Lopez-Jimenez F.

Rev Panam Salud Publica. 2012 Aug;32(2):131-9. Review.

27.

[Current status of cardiac rehabilitation in Chile].

Santibáñez C, Pérez-Terzic C, López-Jiménez F, Cortés-Bergoderi M, Araya MV, Burdiat G.

Rev Med Chil. 2012 May;140(5):561-8. doi: 10.4067/S0034-98872012000500002. Spanish.

28.

Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.

Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A.

Cell Metab. 2011 Aug 3;14(2):264-71. doi: 10.1016/j.cmet.2011.06.011.

29.

Induced pluripotent stem cells: advances to applications.

Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A.

Stem Cells Cloning. 2010 Jan 1;3:29-37.

30.

Cell therapy for heart failure.

Terzic A, Perez-Terzic C.

Rev Esp Cardiol. 2010 Oct;63(10):1117-9. English, Spanish. No abstract available.

31.

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A.

J Am Coll Cardiol. 2010 Aug 24;56(9):721-34. doi: 10.1016/j.jacc.2010.03.066.

32.

Channelopathies: decoding disease pathogenesis.

Terzic A, Perez-Terzic C.

Sci Transl Med. 2010 Jul 28;2(42):42ps37. doi: 10.1126/scitranslmed.3001433.

PMID:
20668296
33.

Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation.

Goel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM.

J Cardiopulm Rehabil Prev. 2010 Jul-Aug;30(4):235-9. doi: 10.1097/HCR.0b013e3181e17387.

PMID:
20551829
34.

Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C.

Stem Cells. 2010 Jul;28(7):1281-91. doi: 10.1002/stem.447.

35.

Current status of cardiac rehabilitation in Latin America and the Caribbean.

Korenfeld Y, Mendoza-Bastidas C, Saavedra L, Montero-Gómez A, Perez-Terzic C, Thomas RJ, Sert-Kuniyoshi F, Vallejos J, Ibañez-Arenas R, Lopez-Jimenez F.

Am Heart J. 2009 Sep;158(3):480-7. doi: 10.1016/j.ahj.2009.06.020. Epub 2009 Aug 4.

PMID:
19699874
36.

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.

Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A.

Circ Res. 2009 Sep 25;105(7):648-56. doi: 10.1161/CIRCRESAHA.109.203109. Epub 2009 Aug 20.

37.

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A.

Circulation. 2009 Aug 4;120(5):408-16. doi: 10.1161/CIRCULATIONAHA.109.865154. Epub 2009 Jul 20.

38.

Guided stem cell cardiopoiesis: discovery and translation.

Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A.

J Mol Cell Cardiol. 2008 Oct;45(4):523-9. doi: 10.1016/j.yjmcc.2008.09.122. Epub 2008 Sep 26. Review.

39.

Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A.

Stem Cells. 2008 Oct;26(10):2644-53. doi: 10.1634/stemcells.2008-0187. Epub 2008 Jul 31.

40.

Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.

Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederländer NJ, Jeganathan K, Yamada S, Reyes S, Rowe L, Hiddinga HJ, Eberhardt NL, Terzic A, van Deursen JM.

Nat Cell Biol. 2008 Jul;10(7):825-36. doi: 10.1038/ncb1744. Epub 2008 May 30. Erratum in: Nat Cell Biol. 2012 Jun;14(6):649. Pitel, Kevin [corrected to Pitel, Kevin S].

41.

Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.

Park S, Lim BB, Perez-Terzic C, Mer G, Terzic A.

J Proteome Res. 2008 Apr;7(4):1721-8. doi: 10.1021/pr7007847. Epub 2008 Mar 1.

42.

Genomic chart guiding embryonic stem cell cardiopoiesis.

Faustino RS, Behfar A, Perez-Terzic C, Terzic A.

Genome Biol. 2008 Jan 9;9(1):R6. doi: 10.1186/gb-2008-9-1-r6.

43.

Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics.

Arrell DK, Niederländer NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A.

Clin Pharmacol Ther. 2007 Sep;82(3):316-9. Epub 2007 Aug 1. Review.

PMID:
17671447
44.

Nuclear transport: target for therapy.

Faustino RS, Nelson TJ, Terzic A, Perez-Terzic C.

Clin Pharmacol Ther. 2007 Jun;81(6):880-6. Epub 2007 Apr 18. Review.

PMID:
17443136
45.

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair.

Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederländer N, Alekseev AE, Zingman LV, Terzic A.

J Exp Med. 2007 Feb 19;204(2):405-20. Epub 2007 Feb 5.

46.

Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery.

Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederländer NJ, Behfar A, Terzic A.

Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S68-76.

PMID:
17230218
47.

Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells.

Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A.

Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S60-7.

48.

Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice.

Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM.

J Cell Biol. 2006 Feb 13;172(4):529-40.

49.

Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair.

Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Pucéat M, Terzic A.

Ann N Y Acad Sci. 2005 May;1049:189-98.

PMID:
15965118
50.

ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits.

Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A.

Diabetes. 2004 Dec;53 Suppl 3:S169-75.

Supplemental Content

Loading ...
Support Center